5.71
-0.0107(-0.19%)
Currency In USD
| Previous Close | 5.72 |
| Open | 5.85 |
| Day High | 5.98 |
| Day Low | 5.64 |
| 52-Week High | 5.91 |
| 52-Week Low | 1.99 |
| Volume | 101,779 |
| Average Volume | 137,137 |
| Market Cap | 215.66M |
| PE | -6.72 |
| EPS | -0.85 |
| Moving Average 50 Days | 4.04 |
| Moving Average 200 Days | 3.42 |
| Change | -0.01 |
If you invested $1000 in Genelux Corporation (GNLX) since IPO date, it would be worth $928.34 as of October 20, 2025 at a share price of $5.709. Whereas If you bought $1000 worth of Genelux Corporation (GNLX) shares 1 year ago, it would be worth $2,154.45 as of October 20, 2025 at a share price of $5.709.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Genelux Corporation to Participate in a Fireside Chat at H.C. Wainwright Global Investment Conference
GlobeNewswire Inc.
Sep 02, 2025 8:01 PM GMT
WESTLAKE VILLAGE, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick, President, CEO and Chairman of the Board and Matt Pulisic, Chief F
Genelux Corporation Announces Appointment of Eric Groen as General Counsel, Corporate Secretary, Chief Compliance Officer and Head of Business Development
GlobeNewswire Inc.
Jul 07, 2025 11:00 AM GMT
WESTLAKE VILLAGE, Calif., July 07, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced the appointment of Eric Groen as General Counsel, Corporate Secretary, Chief Compliance
Genelux Corporation to Participate in a Fireside Chat at the Citizens Life Sciences Conference
GlobeNewswire Inc.
May 01, 2025 8:05 PM GMT
WESTLAKE VILLAGE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick, President, CEO and Chairman of the Board, and Matt Pulisic, CFO, wil